Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Celldex Therapeutics (CLDX) Leases (2019 - 2025)

Celldex Therapeutics (CLDX) has 7 years of Leases data on record, last reported at $2.4 million in Q4 2025.

  • For Q4 2025, Leases fell 37.48% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $2.4 million, down 37.48%, while the annual FY2025 figure was $2.4 million, 37.48% down from the prior year.
  • Leases reached $2.4 million in Q4 2025 per CLDX's latest filing, down from $2.7 million in the prior quarter.
  • Across five years, Leases topped out at $4.0 million in Q4 2022 and bottomed at $2.2 million in Q1 2024.
  • Average Leases over 5 years is $3.1 million, with a median of $3.1 million recorded in 2021.
  • Peak YoY movement for Leases: plummeted 40.41% in 2024, then skyrocketed 62.31% in 2025.
  • A 5-year view of Leases shows it stood at $3.0 million in 2021, then skyrocketed by 34.71% to $4.0 million in 2022, then plummeted by 35.59% to $2.6 million in 2023, then surged by 51.26% to $3.9 million in 2024, then tumbled by 37.48% to $2.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Leases were $2.4 million in Q4 2025, $2.7 million in Q3 2025, and $3.1 million in Q2 2025.